Abstract
With hundreds of fungal meningitis infections and dozens of deaths caused by contaminated methylprednisolone manufactured at the New England Compounding Center (NECC), patients and health professionals alike are wondering how this could have happened. Recently released reports documenting FDA's inspections of NECC and allied company Ameridose have shed some light on the question.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
